NCT01679665View on ClinicalTrials.gov

Systems Biology of Vaccination for EV71 Vaccine in Humans

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Systems BiologyEarly GeneEV71 Vaccine
Interventions
BIOLOGICAL

320U /0.5ml

inactivated vaccine(vero cell) against EV71 of 320U /0.5ml, two doses, 4 weeks interval

BIOLOGICAL

0/0.5ml placebo

0/0.5ml placebo, two doses, 4 weeks interval

Trial Locations (1)

210009

Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing

All Listed Sponsors
collaborator

Bejing Vigoo Biological Co., LTD

INDUSTRY

lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT01679665 - Systems Biology of Vaccination for EV71 Vaccine in Humans | Biotech Hunter | Biotech Hunter